Clinical neuroimmunology.
Clinical research has focused on autoimmune disease (AID) for a couple of decades. More sensitive and specific methods have been developed for neuroimmunological research. Gamma fraction bands (bands separated by electrophoresis and visualized by amino black staining) and IgG fraction bands (bands separated by iso-electric focusing and visualized by immunostaining) are used instead of oligoclonal bands. Myasthenia gravis (MG) mainly involves acetylcholine receptors of the postsynaptic membrane at the neuromuscular junction. Myasthenia gravis has been considered to be a generalized AID, because 7% of patients with myasthenia gravis associate with other AIDs and more than one autoimmune antibody is detected in 52.5% patients with myasthenia gravis. Pyramidal signs in myasthenia gravis patients are described; the possible mechanism may at least be partly due to the acetylcholine receptor antibody. P2 protein and its antibody are studied in patients with acute and chronic inflammatory demyelinating polyneuropathy.
Xu
X
X
Department of Neurology, Beijing Hospital, Beijing, P. R. China.
Zhang
H
H
Guo
H
H
Wang
X
X
Sun
H
H
Han
X
X
Li
B
B
Pang
F
F
Wang
H
H
Wen
S G
SG
Jiang
Y
Y
Tan
M
M
D000293:Adolescent; D000328:Adult; D000368:Aged; D000486:Allergy and Immunology / Q000193:education*; D001327:Autoimmune Diseases / Q000276:immunology* / Q000628:therapy; D002648:Child; D002675:Child, Preschool; D003711:Demyelinating Diseases / Q000276:immunology / Q000628:therapy; D005260:Female; D006801:Humans; D007111:Immunity, Cellular / Q000276:immunology; D008297:Male; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000276:immunology / Q000628:therapy; D009157:Myasthenia Gravis / Q000276:immunology / Q000628:therapy; D015213:Neuroimmunomodulation / Q000276:immunology*; D009462:Neurology / Q000193:education*; D011129:Polyradiculoneuropathy / Q000276:immunology / Q000628:therapy